Email this article USE OF MATHEMATICAL MODEL FOR DETERMINATION OF VIRUSNEUTRALIZING ACTIVITY OF ANTIBODIES DURING EXPERIMENTAL SHIV-INFECTION
- Authors: Klots I.N1
-
Affiliations:
- Research Institute of Medical Primatology, SochiAdler, Russia
- Issue: Vol 86, No 2 (2009)
- Pages: 68-70
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.04.2009
- URL: https://microbiol.crie.ru/jour/article/view/13304
- ID: 13304
Cite item
Full Text
Abstract
Aim. To study the role of neutralizing antibodies (NA) on the model of SHIV-infection in pig-tailed macaques immunized by different methods. Materials and methods. Titers of NA were determined using TZM-bl cells; titers corresponding to 50% neutralization were determined from serum dilution — relative luminescence graph. We have proposed to use index of integral neutralizing activity, which mathematically expressed as integral of neutralization function in serum dilutions interval from 1 (or first dilution used) to that giving selected titer (we selected 50% neutralization). Results. On the basis of analysis of data on course of SHIV-infection in previously immunized macaques it was concluded that more clear correlation exists between results of infection and integral neutralizing activity of serum compared with NA titers corresponding to 50% neutralization. Conclusion. Proposed method could be useful for analysis of immunization efficacy against HIV infection.
Full Text
ИСПОЛЬЗОВАНИЕ МАТЕМАТИЧЕСКОЙ МОДЕЛИ ДЛЯ ОПРЕДЕЛЕНИЯ ВИРУСНЕЙТРАЛИЗУЮЩЕЙ АКТИВНОСТИ АНТИТЕЛ ПРИ ЭКСПЕРИМЕНТАЛЬНОЙ SHIVИНФЕКЦИИ×
References
- Li Y., Cleveland B., Klots I. et al. Removal of a single N-linked glycan in HIV-1 gp120 results in enhanced ability to induce neutralizing antibody responses. J.Virology. 2008, 82: 638—651.
- Mascola J.R. Defining the protective antibody response for HIV-1. Curr. Mol. Med. 2003, 3: 209—216.
- Reimann K.A., Li J.T, Veazey R. et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate Env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J.Virology. 1996, 70: 6922—6928.
- Sakuragi S., Shibata R., Mukai R. et al. Infection of macaques monkeys with a chimeric human and simian immunodeficiency virus. J. Gen. Virol. 1992, 73: 2983—2987.
- Shibata R., Kawamura M., Sakai H. et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virology. 1991, 65: 3514—3520.
- Wei X., Decker J.M., Liu H. et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46: 1896—1905.
Supplementary files
